CDEK
← All drugs Report issue

cc-90006

mAbexperimental

Clinical trial activity

2 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2016 (NCT02934269)

Timeline

2010s

  1. Jan 1, 2016

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • cc-90006

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03337022Phase 1Dec 21, 2017Celgene
NCT02934269Phase 1Nov 1, 2016Celgene
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
CelgeneFor profit2212016
1 organizations
Page 1 / 1